BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16619688)

  • 1. Burkitt's lymphoma and emerging therapeutic strategies for EBV and AIDS-associated lymphoproliferative diseases in East Africa.
    Mwanda WO; Whalen C; Remick SC
    East Afr Med J; 2005 Sep; 82(9 Suppl):S133-4. PubMed ID: 16619688
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool.
    Langerak AW; Moreau E; van Gastel-Mol EJ; van der Burg M; van Dongen JJ
    Leukemia; 2002 Aug; 16(8):1572-3. PubMed ID: 12145705
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cutting-edge of medicine; Epstein-Barr virus associated lymphoproliferative disorders: disease concept and treatment].
    Suzuki R
    Nihon Naika Gakkai Zasshi; 2013 Apr; 102(4):979-85. PubMed ID: 23772516
    [No Abstract]   [Full Text] [Related]  

  • 5. The contribution of the Epstein-Barr virus to the pathogenesis of childhood lymphomas.
    Cader FZ; Kearns P; Young L; Murray P; Vockerodt M
    Cancer Treat Rev; 2010 Jun; 36(4):348-53. PubMed ID: 20193983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorectal lymphoma without effusion associated with human herpesvirus-8 and type 1 Epstein-Barr virus in an HIV-infected patient.
    Navarro JT; Ribera JM; Juncà J; Millá F
    Hum Pathol; 2003 Jun; 34(6):630. PubMed ID: 12827623
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
    Rowe M; Kelly GL; Bell AI; Rickinson AB
    Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
    Okano M; Gross TG
    Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-related lymphoproliferative disorders.
    Wagner-Johnston ND; Ambinder RF
    Curr Hematol Malig Rep; 2007 Oct; 2(4):249-54. PubMed ID: 20425377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease.
    Berger C; Day P; Meier G; Zingg W; Bossart W; Nadal D
    J Med Virol; 2001 Aug; 64(4):505-12. PubMed ID: 11468736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zidovudine: a targeted therapy for endemic Burkitt's lymphoma.
    Kurokawa M; Andela V; Ghosh S; Barreto JE; Harrington W
    East Afr Med J; 2005 Sep; 82(9 Suppl):S150-4. PubMed ID: 16619691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [INFECTIONS CAUSED BY EPSTEIN-BARR VIRUS IN HIV-INFECTED PATIENTS].
    Puzyreva LV; Safonov AD
    Zh Mikrobiol Epidemiol Immunobiol; 2016 Nov; (6):108-116. PubMed ID: 30695397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the association of Epstein-Barr virus with Burkitt's lymphoma occurring in a Chinese population.
    Chan JK; Tsang WY; Ng CS; Wong CS; Lo ES
    Histopathology; 1995 Mar; 26(3):239-45. PubMed ID: 7797201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated lymphomas.
    Gandhi MK
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Association between meningeal Burkitt lymphoma and Epstein-Barr virus in an HIV-infected patient].
    López G; Marcilla F; Ramos C; Arazo P
    Enferm Infecc Microbiol Clin; 2007 Dec; 25(10):658. PubMed ID: 18053481
    [No Abstract]   [Full Text] [Related]  

  • 20. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas.
    Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M
    J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.